Maynard Um
-
-
-
-
-
-
-
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
GeneDx (WGS) PT Lowered to $75 at Canaccord
-
-
-
-
-
-
-
GeneDx (WGS) PT Lowered to $170 at BTIG
-
-
-
-
-
-
-
GeneDx launches prenatal whole genome sequencing test
-
-
-
-
-
-
-
Canaccord Genuity Starts GeneDx (WGS) at Buy
-
-
-
-
-
-
-
GeneDx (WGS) PT Raised to $125 at BTIG
-
-
-
-
-
-
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
404,871 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

